In a setback for Merck, a federal judge refused to dismiss a whistleblower lawsuit that accuses the drugmaker of distorting so-called nominal pricing in order to build a huge customer base for its Nuv…
In a setback for Merck, a federal judge refused to dismiss a whistleblower lawsuit that accuses the drugmaker of distorting so-called nominal pricing in order to build a huge customer base for its Nuv…
UPDATED ITEM: As indicated earlier, Amgen has agreed to pay $762 million to resolve off-label marketing charges brought by the US Department of Justice as the result of a whistleblower lawsuit and ple…
A former Abbott Laboratories sales rep has filed a whistleblower lawsuit against the drugmaker, claiming the TriCor cholesterol drug was illegally promoted for nearly a decade. This is the latest in a…
